Abstract:MicroRNAs (miRs) are endogenously expressed small noncoding RNA molecules that are able to regulate gene expression on the posttranscriptional level by binding to the mRNAs of their target genes, thus inducing inhibition of translation or mRNA degradation. The miR-17–92 cluster (encoding miR-17, -18a, -19a, -20a, -19b and miR-92a) was shown to augment tumor angiogenesis if overexpressed in tumor cells. Whereas miR-92a was recently identified as negative regulator of vessel growth, the individual functions of the other members of the miR-17–92 cluster in endothelial cells is less clear and only a combination of miR-17, -18a and -20a was shown to partially rescue the defective angiogenesis under conditions of Dicer deficiency. To investigate the involvement of the individual members of the miR-17–92 cluster in angiogenesis, human umbilical vein endothelial cells (HUVECs) were transfected with precursor molecules for miR-17, -18a, -19a and -20a. Overexpression of the different members significantly inhibited 3D spheroid sprouting (Pre-17:10±3%,-18a: 28±5%,-19a: 45±4%,-20a: 33±8% of control) and impaired the assembly of capillary networks in vitro. Conversely, inhibition of miR-17 (142±15% of control), miR-18a (152±6% of control) and miR-20a (153±9% of control) augmented spheroid sprout formation. Next, we addressed the in vivo relevance by using antagomirs to block the individual miRs. Antagomir-17 (which also blocks miR-20a) significantly increased the number of lectin-positive vessels in matrigel plugs (190±26% of control), whereas antagomirs, which specifically affect miR-18a and miR-19a were less effective. Antagomir-17 additionally improved blood flow after hind limb ischemia (217±24% of control) and increased tumor growth (140±14% of control). To identify direct targets of miR-17, we combined microarray gene expression analysis with target prediction. Among others, Janus kinase 1 (Jak1) was significantly downregulated on mRNA (38±5% of control) and protein (41±14% of control) level by miR-17. In summary, we show that the individual members of the miR-17–92 clusters exhibit a cell intrinsic anti-angiogenic activity in endothelial cells. Inhibition of miR-17 efficiently increased neovascularization and tumor growth in vivo.

MiR-19b-1 Inhibits Angiogenesis by Blocking Cell Cycle Progression of Endothelial Cells

MiR-29a modulates the angiogenic properties of human endothelial cells.

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

MiR-181b suppresses angiogenesis by directly targeting cellular communication network factor 1

Over expressing miR-19b-1 suppress breast cancer growth by inhibiting tumor microenvironment induced angiogenesis.

Evaluation Of Mir-29c Inhibits Endotheliocyte Migration And Angiogenesis Of Human Endothelial Cells By Suppressing The Insulin Like Growth Factor 1

Abstract 5756: The MicroRNA-17–92 Cluster Exhibits a Cell Intrinsic Anti-angiogenic Function in Endothelial Cells

Mir-17-3p Inhibits Angiogenesis by Downregulating Flk-1 in the Cell Growth Signal Pathway

MicroRNA-29b-3p Inhibits Cell Proliferation and Angiogenesis by Targeting VEGFA and PDGFB in Retinal Microvascular Endothelial Cells.

Endothelial Mir-17∼92 Cluster Negatively Regulates Arteriogenesis Via Mirna-19 Repression of WNT Signaling

microRNA-15b-5p Regulates Vascular Endothelial Growth Factor Signaling Through VEGFR2 in Human Umbilical Vein Endothelial Cells

Abstract 103: MiR-4261 Controls Endothelial Cells Angiogenesis

Mir-302 Cluster Inhibits Angiogenesis and Growth of K562 Leukemia Cells by Targeting VEGFA.

Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters

MicroRNAs modulating angiogenesis: miR-129-1 and miR-133 act as angio-miR in HUVECs

MiRNA-29b Suppresses Tumor Growth Through Simultaneously Inhibiting Angiogenesis and Tumorigenesis by Targeting Akt3

MicroRNA‐185 inhibits angiogenesis in human microvascular endothelial cells through targeting stromal interaction molecule 1

A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.

MiR-148b-3p Inhibits Renal Carcinoma Cell Growth and Pro-Angiogenic Phenotype of Endothelial Cell Potentially by Modulating FGF2.

miR-5586-5p suppresses hypoxia-induced angiogenesis through multiple targeting of HIF-1α, HBEGF, and ADAM17 in breast cancer

Abstract 23: Microrna302-367 Sphingosine 1 Phosphate Receptor 1 Pathway Prevents Tumor Growth Via Restricting Angiogenesis and Enhancing Vascular Stability